17443290

Source:http://linkedlifedata.com/resource/pubmed/id/17443290

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0005516, umls-concept:C0006118, umls-concept:C0027651, umls-concept:C0086418, umls-concept:C0386370, umls-concept:C0439852, umls-concept:C1514485, umls-concept:C1520166, umls-concept:C1627358, umls-concept:C2349975
pubmed:issue	2
pubmed:dateCreated	2007-5-16
pubmed:abstractText	Ferumoxtran-10 belongs to the Ultra Small Particles of Iron Oxide (USPIO) class of contrast agents and induces delayed tumor enhancement in brain tumors, reflecting the trapping of iron oxide particles by the macrophages and activated microglia. The aim of the study was to compare Ferumoxtran-10 contrast enhancement in four human high-grade glioma xenograft models (TCG2, TCG3, TCG4, and U87) with different growing profiles.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8309335
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Contrast Media, http://linkedlifedata.com/resource/pubmed/chemical/Dextrans, http://linkedlifedata.com/resource/pubmed/chemical/Ferumoxytol, http://linkedlifedata.com/resource/pubmed/chemical/Iron, http://linkedlifedata.com/resource/pubmed/chemical/Magnetite Nanoparticles, http://linkedlifedata.com/resource/pubmed/chemical/Oxides, http://linkedlifedata.com/resource/pubmed/chemical/ferumoxtran-10
pubmed:status	MEDLINE
pubmed:month	Jun
pubmed:issn	0167-594X
pubmed:author	pubmed-author:BracardSergeS, pubmed-author:BressenotAudeA, pubmed-author:KremerStéphaneS, pubmed-author:PinelSophieS, pubmed-author:PlénatFrançoisF, pubmed-author:RobertPhilippeP, pubmed-author:VédrinePierre-OlivierPO
pubmed:issnType	Print
pubmed:volume	83
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	111-9
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:17443290-Animals, pubmed-meshheading:17443290-Brain Neoplasms, pubmed-meshheading:17443290-Cell Differentiation, pubmed-meshheading:17443290-Cell Proliferation, pubmed-meshheading:17443290-Contrast Media, pubmed-meshheading:17443290-Dextrans, pubmed-meshheading:17443290-Ferumoxytol, pubmed-meshheading:17443290-Glioma, pubmed-meshheading:17443290-Humans, pubmed-meshheading:17443290-Iron, pubmed-meshheading:17443290-Magnetic Resonance Imaging, pubmed-meshheading:17443290-Magnetite Nanoparticles, pubmed-meshheading:17443290-Mice, pubmed-meshheading:17443290-Mice, Nude, pubmed-meshheading:17443290-Mitotic Index, pubmed-meshheading:17443290-Neoplasm Invasiveness, pubmed-meshheading:17443290-Neoplasm Transplantation, pubmed-meshheading:17443290-Oxides, pubmed-meshheading:17443290-Tissue Distribution, pubmed-meshheading:17443290-Transplantation, Heterologous
pubmed:year	2007
pubmed:articleTitle	Ferumoxtran-10 enhancement in orthotopic xenograft models of human brain tumors: an indirect marker of tumor proliferation?
pubmed:affiliation	Service de Neuro-Radiologie, Hôpital Central, CHRU Nancy, Nancy, France. kremers@club-internet.fr
pubmed:publicationType	Journal Article, Comparative Study